Sign inGet started

RYAN UNA S

Insider CIK 1255349 · AMRI Director · RNXT Director · CRTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RNXT RenovoRx, Inc. A Award deriv2026-10-012026-10-0255,924— $055,924SEC↗
RNXT RenovoRx, Inc. A Award deriv2025-10-012025-10-0247,640— $047,640SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2025-06-042025-06-0627,000— $027,000SEC↗
RNXT RenovoRx, Inc. A Award deriv2024-10-012024-10-0225,099— $025,099SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2024-06-052024-06-0727,000— $027,000SEC↗
RNXT RenovoRx, Inc. A Award deriv2023-10-012023-10-0225,099— $025,099SEC↗
QNCX Quince Therapeutics, Inc. A Award deriv2023-05-242023-05-2627,000— $027,000SEC↗
RNXT RenovoRx, Inc. A Award deriv2022-10-012022-10-0425,099— $025,099SEC↗
CRTX Cortexyme, Inc. A Award deriv2022-06-082022-06-0927,000— $027,000SEC↗
RNXT RenovoRx, Inc. J Other2022-04-222026-06-2426,838$0.93 $25.0K80,959SEC↗
RNXT RenovoRx, Inc. J Other2022-04-222026-06-2416,206$1.62 $26.3K97,165SEC↗
RNXT RenovoRx, Inc. A Award deriv2022-03-102022-03-144,582— $04,582SEC↗
RNXT RenovoRx, Inc. J Other2022-03-032026-06-246,332$3.95 $25.0K54,121SEC↗
RNXT RenovoRx, Inc. J Other2022-03-032026-06-2447,789$4.19 $200.2K47,789SEC↗
RNXT RenovoRx, Inc. A Award deriv2021-10-012021-10-0511,154— $011,154SEC↗
CRTX Cortexyme, Inc. A Award deriv2021-06-162021-06-1711,029— $011,029SEC↗
CRTX Cortexyme, Inc. A Award deriv2020-06-082020-06-0911,029— $011,029SEC↗
CRTX Cortexyme, Inc. P Buy2019-05-132020-03-122,875$17.00 $48.9K2,875SEC↗
AMRI ALBANY MOLECULAR RESEARCH M Exercise deriv2017-05-102017-05-115,000$14.47 $72.3K0SEC↗
AMRI ALBANY MOLECULAR RESEARCH M Exercise2017-05-102017-05-115,000$14.47 $72.3K51,845SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2017-02-082017-02-109,358— $09,358SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2017-02-082017-02-103,802— $046,845SEC↗
AMRI ALBANY MOLECULAR RESEARCH M Exercise deriv2016-10-052016-10-065,000$11.83 $59.1K0SEC↗
AMRI ALBANY MOLECULAR RESEARCH F Tax w/h2016-10-052016-10-063,498$16.91 $59.2K43,043SEC↗
AMRI ALBANY MOLECULAR RESEARCH M Exercise2016-10-052016-10-065,000$11.83 $59.1K46,541SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2016-06-152016-06-164,048$14.82 $60.0K41,541SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2016-02-042016-02-086,540$15.77 $103.1K6,540SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2016-02-042016-02-082,854$15.77 $45.0K37,493SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2015-06-122015-06-151,126$19.98 $22.5K34,639SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2015-03-022015-03-046,881$17.05 $117.3K6,881SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2015-03-022015-03-042,639$17.05 $45.0K33,513SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2014-02-042014-02-067,201$10.43 $75.1K7,201SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2014-02-042014-02-063,356$10.43 $35.0K30,874SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2013-06-052013-06-061,434$10.46 $15.0K27,518SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2013-01-312013-02-0412,367$5.99 $74.1K12,367SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2013-01-312013-02-045,843$5.99 $35.0K26,084SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award deriv2012-06-132012-06-1410,000$2.59 $25.9K10,000SEC↗
AMRI ALBANY MOLECULAR RESEARCH A Award2012-06-062012-06-076,224$2.41 $15.0K20,241SEC↗
AMRI ALBANY MOLECULAR RESEARCH P Buy2012-05-222012-05-23200$2.81 $56214,017SEC↗